novolizer formoterol 12 micrograms /dose inhalation powder
mylan ire healthcare limited - formoterol fumatrate dihydrate - powder for inhalation - 12 microgram(s) - selective beta-2-adrenoreceptor agonists; formoterol
novolizer formoterol 6 µg inhal. pwdr. cartr.
viatris healthcare sa-nv - formoterol fumarate dihydrate 0,006 µg - inhalation powder - 6 µg - formoterol fumarate dihydrate 6 µg - formoterol
novolizer formoterol 12 µg inhal. pwdr. cartr.
viatris healthcare sa-nv - formoterol fumarate dihydrate 0,012 µg - inhalation powder - 12 µg - formoterol fumarate dihydrate 12 µg - formoterol
formoterol fumarate- formoterol fumarate dihydrate solution
rhodes pharmaceuticals l.p. - formoterol fumarate (unii: w34shf8j2k) (formoterol - unii:5zz84gcw8b) - formoterol fumarate inhalation solution is indicated for the long-term, twice daily (morning and evening) administration in the maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (copd), including chronic bronchitis and emphysema. formoterol fumarate inhalation solution is not indicated to treat acute deteriorations of chronic obstructive pulmonary disease [see warnings and precautions (5.2)]. formoterol fumarate inhalation solution is not indicated to treat asthma. the safety and effectiveness of formoterol fumarate inhalation solution in asthma have not been established. use of a laba, including formoterol fumarate, without an inhaled corticosteroid is contraindicated in patients with asthma [see warnings and precautions (5.1)]. formoterol fumarate is not indicated for the treatment of asthma. risk summary there are limited available data with formoterol fumarate inhalation solution use in pregnant women to inform a drug-associated risk of adverse developmen
foster nexthaler 100 micrograms6 micrograms per dose inhalation powder
orient europharma (m) sdn bhd - beclomethasone dipropionate; formoterol fumarate -
formoterol clickhaler 12
viatris limited - formoterol fumarate 0.42%{relative} ((micronised)) - powder for inhalation - 12 mcg - active: formoterol fumarate 0.42%{relative} ((micronised)) excipient: lactose monohydrate
symbicort rapihaler budesonide / formoterol fumarate dihydrate 50/3 pressurised metered dose inhaler
astrazeneca pty ltd - formoterol fumarate dihydrate, quantity: 2.25 microgram; budesonide, quantity: 40 microgram - inhalation, pressurised - excipient ingredients: apaflurane; macrogol 1000; povidone - asthma symbicort rapihaler is indicated in adults and adolescents (12 years and older), for the treatment of asthma to achieve overall asthma control, including the relief of symptoms and the reduction of the risk of exacerbations (see section 4.2 dose and method of administration). chronic obstructive pulmonary disease (copd) symbicort 200/6 is indicated for the symptomatic treatment of moderate to severe copd (fev1 < or = 50% predicted normal) in adults with frequent symptoms despite long-acting bronchodilator use, and/or a history of recurrent exacerbations. symbicort is not indicated for the initiation of bronchodilator therapy in copd.
glycopyrronium / formoterol fumarate dihydrate pressurized inhalation suspension aerosol, metered dose
astrazeneca canada inc - formoterol fumarate dihydrate; glycopyrronium (glycopyrronium bromide) - aerosol, metered dose - 5.8mcg; 8.3mcg - formoterol fumarate dihydrate 5.8mcg; glycopyrronium (glycopyrronium bromide) 8.3mcg - antimuscarinics antispasmodics
foster nexthaler inhalation powder 100 mcg6 mcg per dose
orient europharma pte ltd - beclometasone dipropionate anhydrous (micronized); formoterol fumarate dihydrate (micronized) - powder, metered - beclometasone dipropionate anhydrous (micronized) 100mcg/dose; formoterol fumarate dihydrate (micronized) 6mcg/dose
novolizer formoterol 12 microgram powder for inhalation
meda health sales ireland limited - formoterol fumatrate dihydrate - powder for inhalation - 12 microgram - selective beta-2-adrenoreceptor agonists